NEW YORK (GenomeWeb) – Qiagen said yesterday that it has received US Food and Drug Administration Clearance for its Ipsogen JAK2 RGQ real-time PCR kit to aid in the diagnosis of the blood cancer polycythemia vera.
The qualitative in vitro diagnostic test runs on Qiagen's Rotor-Gene Q MDx system and is designed to qualitatively detect the JAK2 V617F/G1849T allele in genomic DNA extracted from EDTA whole blood.